CONFERENCES
ISRAEL NEWS
HEALTH & WELLNESS
WORLD NEWS
MIDDLE EAST
BUSINESS & INNOVATION
OPINION
JP STORE
Login
Login
Subscribe
JPOST DIGITAL LIBRARY
HOME PAGE
BUSINESS & INNOVATION
OPINION
REAL ESTATE LISTINGS
ALIYAH
JERUSALEM POST CONFERENCE
PREMIUM
JP STORE
Categories
ISRAEL NEWS
WORLD NEWS
MIDDLE EAST
ARAB ISRAELI CONFLICT
US POLITICS
DIASPORA
OPINION
PODCAST
JUDAISM
KABBALAH
CHRISTIAN WORLD
HEALTH & WELLNESS
SCIENCE
LAW
ARCHAEOLOGY
OMG
ENVIRONMENT & CLIMATE CHANGE
FOOD & RECIPES
JERUSALEM POST EN ESPANOL
HISTORY
SPONSORED CONTENT
ADVERTISE WITH US
TERMS OF USE
PRIVACY POLICY
CONTACT US
CANCEL SUBSCRIPTION
CUSTOMER SERVICE
ABOUT US
Jerusalem Post
/
Health & Wellness
New study of Ebola may hold answers for long-term COVID-19 immunity
The study, carried out in a joint effort by British and Guinean scientists, is the world's largest and most comprehensive one to date to examine survivors of the Ebola virus.
Nano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells leading to activation of T cells to recognize and attack melanoma.
(photo credit:
PROF. SATCHI-FAINARO
)
By
TOBIAS SIEGAL
OCTOBER 22, 2020 13:53
See more on
ebola virus
|
scientific study
|
immunity
|
Antibodies
RECOMMENDED STORIES
Admitting defeat? Why Hamas officials say the terror group 'lost control' of Gaza
JULY 7, 2025
'Security situation has collapsed': Hamas has lost 80% of its control over Gaza Strip
JULY 7, 2025
Reporter's Notebook: 'Post' meets with top Hebron sheikh who wants to pull out of PA
JULY 6, 2025
IDF cyber chief, retired Iran strategy head piloted fighter jets striking Iran
JULY 6, 2025
Hot Opinion
War doesn't end on the battlefield: Israel must better support veterans with PTSD
By
JPOST EDITORIAL
Israel's midnight strategist: How IDF chief Eyal Zamir rewired the doctrine on Iran
By
ZVIKA KLEIN
,
YONAH JEREMY BOB
As thousands stay away, Ethiopian Israelis pay a heavy price in Gaza war
By
YAAKOV KATZ
Can Donald Trump win a Nobel Peace Prize?
By
AMOTZ ASA-EL